Literature DB >> 22201914

Natural antioxidants in prevention and management of Alzheimer's disease.

Yan Zhao1, Baolu Zhao.   

Abstract

Alzheimer's disease (AD) is the most common neurodegenerative disease that causes dementia in the elderly. As the aging population increases, the prevalence of AD has increased remarkably worldwide and AD has become one of the leading causes of disability and death among the elderly. A number of drugs have been approved for the treatment of AD; however, they produce only modest benefits and have a wide range of side effects. Therefore, extensive studies are underway to identify effective drugs that are free of undesirable side effects. As accumulating evidences have implicated oxidative stress in the initiation and progression of AD, the potential of using nature antioxidants for prevention and treatment of AD has attracted considerable attention. The present review discusses the involvement of oxidative stress in the pathogenesis of AD and the neuroprotective effects of natural antioxidants, such as Ginkgo biloba flavonoids, soybean isoflavones, theanine and nicotine in cell culture and AD transgenic animal models, specifically, their inhibition on Abeta-induced neurotoxicity and the underlined molecular mechanisms.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22201914     DOI: 10.2741/419

Source DB:  PubMed          Journal:  Front Biosci (Elite Ed)        ISSN: 1945-0494


  12 in total

1.  Amyloid beta (Aβ) peptide modulators and other current treatment strategies for Alzheimer's disease (AD).

Authors:  Walter J Lukiw
Journal:  Expert Opin Emerg Drugs       Date:  2012-03-23       Impact factor: 4.191

2.  Therapeutic potential of human amniotic membrane-derived mesenchymal stem cells in APP transgenic mice.

Authors:  Hongliang Jiao; Ke Shi; Weijie Zhang; Liang Yang; Lu Yang; Fangxia Guan; Bo Yang
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

3.  Inhibitory effects of Tabernaemontana divaricata root extract on oxidative stress and neuronal loss induced by amyloid β25-35 peptide in mice.

Authors:  Onrawee Khongsombat; Walika Nakdook; Kornkanok Ingkaninan
Journal:  J Tradit Complement Med       Date:  2017-06-16

Review 4.  Food-Derived Antioxidant Polysaccharides and Their Pharmacological Potential in Neurodegenerative Diseases.

Authors:  Haifeng Li; Fei Ding; Lingyun Xiao; Ruona Shi; Hongyu Wang; Wenjing Han; Zebo Huang
Journal:  Nutrients       Date:  2017-07-19       Impact factor: 5.717

Review 5.  Protective Effect of Antioxidants on Neuronal Dysfunction and Plasticity in Huntington's Disease.

Authors:  Thirunavukkarasu Velusamy; Archana S Panneerselvam; Meera Purushottam; Muthuswamy Anusuyadevi; Pramod Kumar Pal; Sanjeev Jain; Musthafa Mohamed Essa; Gilles J Guillemin; Mahesh Kandasamy
Journal:  Oxid Med Cell Longev       Date:  2017-01-12       Impact factor: 6.543

6.  Antioxidant and Cholinesterase Inhibitory Activities of Ethyl Acetate Extract of Terminalia chebula: Cell-free In vitro and In silico Studies.

Authors:  Mohamed Asik Rajmohamed; Suganthy Natarajan; Premkumar Palanisamy; Akbarsha Mohammad Abdulkader; Archunan Govindaraju
Journal:  Pharmacogn Mag       Date:  2017-10-11       Impact factor: 1.085

Review 7.  Role of the metabolism of branched-chain amino acids in the development of Alzheimer's disease and other metabolic disorders.

Authors:  Baruh Polis; Abraham O Samson
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

Review 8.  Oxidative stress and the pathogenesis of Alzheimer's disease.

Authors:  Yan Zhao; Baolu Zhao
Journal:  Oxid Med Cell Longev       Date:  2013-07-25       Impact factor: 6.543

Review 9.  Mitochondrial dysfunction: different routes to Alzheimer's disease therapy.

Authors:  Pasquale Picone; Domenico Nuzzo; Luca Caruana; Valeria Scafidi; Marta Di Carlo
Journal:  Oxid Med Cell Longev       Date:  2014-08-20       Impact factor: 6.543

10.  Pharmacological basis for application of scutellarin in Alzheimer's disease: Antioxidation and antiapoptosis.

Authors:  Xinyu Hu; Shanshan Teng; Jiawei He; Xiaoqi Sun; Mingzhao Du; Ling Kou; Xiaofeng Wang
Journal:  Mol Med Rep       Date:  2018-09-13       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.